Intersect ENT Enrolls First Patient in Pivotal Study to Evaluate the NOVA Sinus Implant
July 08, 2015 at 08:02 AM EDT
Intersect ENT, Inc. (Nasdaq: XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat ...